Rheumatology International

, Volume 33, Issue 1, pp 239–240

Herpes zoster infection, vaccination and immunocompromised rheumatology patients

Short Communication

DOI: 10.1007/s00296-011-2155-9

Cite this article as:
O’Connor, M.B. & Phelan, M.J. Rheumatol Int (2013) 33: 239. doi:10.1007/s00296-011-2155-9


Varicella is a self-limiting and relatively mild disease of childhood, although it is frequently more severe and complicated among the immunocompromised rheumatology patients on immunomodulator therapies. In addition, future reactivation of the dormant virus in dorsal root ganglia may cause herpes zoster infection, which can be very debilitating. In this manuscript, we discuss the nature of this infection along with its potential vaccine especially among rheumatology patients.


Herpes zoster infection Vaccination Immunocompromised Rheumatology patients 

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Department of RheumatologySouth Infirmary Victoria University HospitalCorkIreland

Personalised recommendations